7-(benzyloxy)heptanenitrile | 147566-01-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 7-(benzyloxy)heptanenitrile
• 英文别名: 7-Phenylmethoxyheptanenitrile
• CAS: 147566-01-6
• 化学式: C₁₄H₁₉NO
• 分子量: 217.311
• InChiKey: CEOBSBCDYYQVAP-UHFFFAOYSA-N

物化性质

• 沸点：
  351.5±25.0 °C(Predicted)
• 密度：
  0.983±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  16
• 可旋转键数：
  8
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  33
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  7-(benzyloxy)heptanenitrile 在 palladium 10% on activated carbon 、 氢气 、 氯化亚砜 作用下， 以 甲醇 、 甲苯 为溶剂， 反应 2.0h， 以51%的产率得到7-氯庚醇腈
  参考文献：
  名称：

  Discovery and SAR study of hydroxyacetophenone derivatives as potent, non-steroidal farnesoid X receptor (FXR) antagonists

  摘要：

  Compound 1 (IC50 = 35.2 +/- 7.2 mu M), a moderate FXR antagonist was discovered via high-throughput screening. Structure-activity relationship studies indicated that the shape and the lipophilicity of the substituents of the aromatic ring affect the activity dramatically, increasing the shape and the lipophilicity of the substituents of the aromatic ring enhances the potency of FXR antagonists. Especially, when the OH at C2 position of the aromatic ring was replaced by the OBn substituent (analog 2b), its activity could be improved to IC50 = 1.1 +/- 0.1 mu M. Besides, the length of the linker and the tetrazole structure are essential for retaining the activity. (C) 2014 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2014.01.032
• 作为产物：
  描述：

  6-羟基己酸甲酯 在 二异丁基氢化铝 、 cesium fluoride 、 silver(l) oxide 作用下， 以 四氢呋喃 、 N,N-二甲基甲酰胺 为溶剂， 反应 14.0h， 生成 7-(benzyloxy)heptanenitrile
  参考文献：
  名称：

  Discovery and SAR study of hydroxyacetophenone derivatives as potent, non-steroidal farnesoid X receptor (FXR) antagonists

  摘要：

  Compound 1 (IC50 = 35.2 +/- 7.2 mu M), a moderate FXR antagonist was discovered via high-throughput screening. Structure-activity relationship studies indicated that the shape and the lipophilicity of the substituents of the aromatic ring affect the activity dramatically, increasing the shape and the lipophilicity of the substituents of the aromatic ring enhances the potency of FXR antagonists. Especially, when the OH at C2 position of the aromatic ring was replaced by the OBn substituent (analog 2b), its activity could be improved to IC50 = 1.1 +/- 0.1 mu M. Besides, the length of the linker and the tetrazole structure are essential for retaining the activity. (C) 2014 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2014.01.032

文献信息

• Substituted hydroxyureas
  申请人：Ortho Pharmaceutical Corporation

  公开号：US05066658A1

  公开（公告）日：1991-11-19

  The present invention relates to substituted hydroxyureas. These compounds inhibit the enzyme 5-lipoxygenase. In addition, certain of the compounds also inhibit the enzyme-cyclooxygenase. The compounds are useful for treating asthma, allergies, arthritis, posoriasis, ischemia, dermatitis, inflammation and/or broncho-constriction and/or inflammatory diseases of the eye.

  本发明涉及取代脲醇。这些化合物抑制5-脂氧合酶酶。此外，其中某些化合物还抑制酶-环氧合酶。这些化合物用于治疗哮喘、过敏、关节炎、银屑病、缺血、皮炎、炎症和/或支气管收缩和/或眼部炎症性疾病。
• [EN] NLRP3 MODULATORS<br/>[FR] MODULATEURS DE NLRP3
  申请人：INNATE TUMOR IMMUNITY INC

  公开号：WO2019014402A1

  公开（公告）日：2019-01-17

  The present invention provides compounds of Formula (I): (I) wherein all of the variables are as defined herein. These compounds are modulators of NLRP3, which may be used as medicaments for the treatment of proliferative disorders, such as cancer in a subject (e.g., a human).

  本发明提供了Formula (I)的化合物：(I)其中所有变量均如本文所定义。这些化合物是NLRP3的调节剂，可用作治疗增殖性疾病的药物，例如在受试者（例如人类）中的癌症治疗。
• Ni-Catalyzed Isomerization–Hydrocyanation Tandem Reactions: Access to Linear Nitriles from Aliphatic Internal Olefins
  作者：Jihui Gao、Jie Ni、Rongrong Yu、Gui-Juan Cheng、Xianjie Fang

  DOI：10.1021/acs.orglett.0c04007

  日期：2021.1.15

  A highly regioselective nickel-based catalyst system for the isomerization/hydrocyanation of aliphatic internal olefins is described. This benign tandem reaction provides facile access to a wide variety of aliphatic nitriles in good yields with excellent regioselectivities. Thanks to Lewis acid-free conditions, the protocol features board functional groups tolerance, including secondary amine and unprotected

  描述了用于脂肪族内烯烃的异构化/氢氰化的高度区域选择性的镍基催化剂体系。这种良性串联反应可轻松获得各种脂肪族腈，且产率高，具有良好的区域选择性。由于无路易斯酸条件，该方案具有电路板官能团的耐受性，包括仲胺和未保护的醇基。
• NLRP3 modulators
  申请人：Innate Tumor Immunity, Inc.

  公开号：US11344543B2

  公开（公告）日：2022-05-31

  The present invention provides compounds of Formula (I): (I) wherein all of the variables are as defined herein. These compounds are modulators of NLRP3, which may be used as medicaments for the treatment of proliferative disorders, such as cancer in a subject (e.g., a human).

  本发明提供了式 (I) 的化合物：(I)，其中所有变量如本文所定义。这些化合物是 NLRP3 的调节剂，可用作治疗受试者（例如人类）增殖性疾病（如癌症）的药物。
• 10.1021/acs.joc.4c01106
  作者：Yan, Yonggang、Wang, Pengpeng、Dong, Jianyang、Li, Gang、Wang, Chao、Xue, Dong

  DOI：10.1021/acs.joc.4c01106

  日期：——

  the predominant method for the synthesis of adiponitrile, which is an important precursor for polymer production. However, the use of fossil-derived alkenes raises environmental concerns, and hydrogen cyanide is highly volatile and extremely toxic. Herein, we report the use of biomass-derived 1,4-butanediol, as well as other primary alcohols, for photochemical synthesis of linear and branched nitriles

  镍催化的 1,3-丁二烯与氰化氢气体的氢氰化是合成己二腈的主要方法，而己二腈是聚合物生产的重要前体。然而，使用化石衍生的烯烃会引起环境问题，而且氰化氢具有高度挥发性和剧毒性。在此，我们报道了使用生物质衍生的 1,4-丁二醇以及其他伯醇，以 1,4-二氰基苯作为 CN 源，进行直链和支链腈和二腈（包括己二腈）的光化学合成。这种温和、可持续的方法不需要氰化氢气体或对空气或湿气敏感的金属催化剂，适用于生产作为二胺前体的二腈，这对于开发新型聚酰胺具有潜在的用途。